Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berra Yazar-Klosinski

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Nature Medicine|October 12, 2021
Reply to: Caution at psychiatry's psychedelic frontier and Challenges with benchmarking of MDMA-assisted psychotherapyJennifer Mitchell, Allison Coker, Berra Yazar-Klosinski
Current Drug Abuse Reviews|May 1, 2013
Can MDMA play a role in the treatment of substance abuse?Lisa Jerome, Shira Schuster, B Berra Yazar-Klosinski
The American Journal of Drug and Alcohol Abuse|April 14, 2017
Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational studyGeoffrey E Noller, Chris M Frampton, Berra Yazar-Klosinski
ACS Omega|January 17, 2022
Fully Validated, Multi-Kilogram cGMP Synthesis of MDMAJay B Nair, Linda Hakes, Berra Yazar-Klosinski, et al.
Plos One|October 14, 2020
The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSDElliot Marseille, James G Kahn, Berra Yazar-Klosinski, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 31, 2015
MDMA-assisted therapy: A new treatment model for social anxiety in autistic adultsAlicia L Danforth, Christopher M Struble, Berra Yazar-Klosinski, et al.
The Journal of Nervous and Mental Disease|March 6, 2014
Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseasesPeter Gasser, Dominique Holstein, Yvonne Michel, et al.
Focus (American Psychiatric Publishing)|July 5, 2023
Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and SertralineAllison A Feduccia, Lisa Jerome, Berra Yazar-Klosinski, et al.
Frontiers in Psychiatry|October 2, 2019
Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and SertralineAllison A Feduccia, Lisa Jerome, Berra Yazar-Klosinski, et al.
Frontiers in Psychiatry|November 21, 2022
MDMA-assisted therapy is associated with a reduction in chronic pain among people with post-traumatic stress disorderDevon Christie, Berra Yazar-Klosinski, Ekaterina Nosova, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Nature Medicine|October 12, 2021
Reply to: Caution at psychiatry's psychedelic frontier and Challenges with benchmarking of MDMA-assisted psychotherapyJennifer Mitchell, Allison Coker, Berra Yazar-Klosinski
Current Drug Abuse Reviews|May 1, 2013
Can MDMA play a role in the treatment of substance abuse?Lisa Jerome, Shira Schuster, B Berra Yazar-Klosinski
The American Journal of Drug and Alcohol Abuse|April 14, 2017
Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational studyGeoffrey E Noller, Chris M Frampton, Berra Yazar-Klosinski
ACS Omega|January 17, 2022
Fully Validated, Multi-Kilogram cGMP Synthesis of MDMAJay B Nair, Linda Hakes, Berra Yazar-Klosinski, et al.
Plos One|October 14, 2020
The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSDElliot Marseille, James G Kahn, Berra Yazar-Klosinski, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 31, 2015
MDMA-assisted therapy: A new treatment model for social anxiety in autistic adultsAlicia L Danforth, Christopher M Struble, Berra Yazar-Klosinski, et al.
The Journal of Nervous and Mental Disease|March 6, 2014
Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseasesPeter Gasser, Dominique Holstein, Yvonne Michel, et al.
Focus (American Psychiatric Publishing)|July 5, 2023
Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and SertralineAllison A Feduccia, Lisa Jerome, Berra Yazar-Klosinski, et al.
Frontiers in Psychiatry|October 2, 2019
Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and SertralineAllison A Feduccia, Lisa Jerome, Berra Yazar-Klosinski, et al.
Frontiers in Psychiatry|November 21, 2022
MDMA-assisted therapy is associated with a reduction in chronic pain among people with post-traumatic stress disorderDevon Christie, Berra Yazar-Klosinski, Ekaterina Nosova, et al.
Pageof 4